| Financial Year |
March 31 2023 |
| Monetary Funds |
140,644,943.61 |
| Held-for-trading Financial Assets |
109,310,153.24 |
| Notes Receivable |
13,950,082.86 |
| Accounts Receivable |
674,724,165.11 |
| Advances to Suppliers |
14,625,014.76 |
| Other Receivables |
865,006.07 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
87,270,896.06 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,770,611.67 |
| Total Current Assets |
1,236,350,281.05 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
392,363,240.17 |
| Under-construction Projects |
67,373,186.69 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
49,598,142.79 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
9,571,607.56 |
| Other Non-Current Assets |
85,196,536.68 |
| Sub-Total of Non-Current Assets |
743,952,148.64 |
| Total Assets |
1,980,302,429.69 |
| Short-Term Loans |
214,367,705.12 |
| Trading Financial liabilities |
-- |
| Notes Payable |
70,000,000.00 |
| Accounts Payable |
130,135,253.91 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
18,080,121.20 |
| Taxes Payable |
8,522,455.46 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
466,429.84 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
280,043.90 |
| Sub-Total of Current Liabilities |
445,224,553.27 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
13,133,810.95 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
24,659,901.47 |
| Total Liabilities |
469,884,454.74 |
| Paid-In Capital(Or Share Stock) |
201,600,000.00 |
| Capital Surplus |
548,262,833.79 |
| Surplus Reserve |
99,206,803.80 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
584,625,269.26 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,510,417,974.95 |
| Owner's Equity（Stockholder's Equity） |
1,510,417,974.95 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,980,302,429.69 |
